Pulse Biosciences, Inc Common Stock (DE)

PLSENASDAQUSD
24.55 USD
2.55 (9.41%)AT CLOSE (11:59 AM EDT)
24.69
0.14 (0.59%)
POST MARKET (AS OF 07:45 PM EDT)
Post Market
AS OF 07:45 PM EDT
24.69
0.14 (0.59%)
🔴Market: CLOSED
Open?$26.15
High?$26.80
Low?$23.74
Prev. Close?$27.10
Volume?570.7K
Avg. Volume?335.6K
VWAP?$24.73
Rel. Volume?1.70x
Bid / Ask
Bid?$21.21 × 100
Ask?$28.30 × 100
Spread?$7.09
Midpoint?$24.76
Valuation & Ratios
Market Cap?1.7B
Shares Out?68.2M
Float?17.5M
Float %?25.9%
P/E Ratio?N/A
P/B Ratio?25.63
EPS?-$1.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Employees
116
Market Cap
1.7B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2016-05-18
Address
3957 POINT EDEN WAY
HAYWARD, CA 94545
Phone: 510-906-4600
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?7.26Strong
Quick Ratio?7.24Strong
Cash Ratio?6.97Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUED
Score
50/100
P/E?
N/A
P/B?
25.63HIGH
P/S?
2,262.45HIGH
P/FCF?
N/A
EV/EBITDA?
-21.2CHEAP
EV/Sales?
2,171.48HIGH
Returns & Efficiency
ROE?
-112.5%WEAK
ROA?
-91.4%WEAK
Cash Flow & Enterprise
FCF?$-55499000
Enterprise Value?$1.6B
Fundamentals ratios updated end of day